Telemedicine visits can make physicians more efficient, but the ability to report symptoms can add to the workload burden as staff try to figure out which symptoms need to be addressed, said Susan Escudier, MD, FACP, vice president of value-based care and quality programs, Texas Oncology.
Telemedicine visits can make physicians more efficient, but the ability to report symptoms can add the workload burden as staff try to figure out which symptoms need to be addressed, said Susan Escudier, MD, FACP, vice president of value-based care and quality programs, Texas Oncology.
Transcript
Are digital health solutions streamlining providers' work or adding more to their plate?
I think that telemedicine visits make physicians more efficient, assuming it works the first time. But you can sit at your desk, and I can talk to 1, 2, 3, 4 patients in a row, quickly. I don’t have to wait for someone to take their blood pressure and move them out of the room.
I would say that there are times when it’s more of a burden, just because of the technology. The need for the technology really took off in the pandemic, and it was maybe a little earlier than it was ready to go. But the one I do worry about is the patient-reported symptoms, because I think it can get overwhelming for the nursing staff, and we’ve had to figure out as a group, do we address everything the patient mentions? I mean, if they’re tired, well, I’m tired, you’re tired, you know? I think we’ve tried to focus on higher degrees of symptoms.
But that worries me a little bit about having sort of every patient itch and rash and lumps or bumps having to be transmitted to the chart and dealt with. I think that, to me, is an important question of how to filter the information so we get what’s important.
Persistence Pays Off With Zanubrutinib: A Challenging CLL Case With a Prior BTK Inhibitor Failure
May 10th 2024The case of a 77-year-old woman with a long chronic lymphocytic leukemia (CLL) history illustrates the novel use of zanubrutinib as a potential option for some patients who have failed first-generation Bruton tyrosine kinase (BTK) inhibitors and venetoclax.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
Margin Status Likely Not a Factor in STS Recurrence
May 10th 2024The optimal negative margin required following surgical resection and perioperative radiotherapy for extremity soft tissue sarcoma (STS) remains up for debate, with investigators of a new study using Union for International Cancer Control classification to define resection margin.
Read More